Novaresp
21 employees on LinkedIn · 1 known investors
NovaResp develops cMAP, an AI and machine learning software platform that works with CPAP/PAP machines to predict and prevent apnea episodes before they occur, allowing therapy at lower, more comfortable air pressures. The product targets treatment of Obstructive Sleep Apnea to improve patient adherence to CPAP therapy.
Investors · 1
Frequently asked questions
- What does Novaresp do?
- NovaResp develops cMAP, an AI and machine learning software platform that works with CPAP/PAP machines to predict and prevent apnea episodes before they occur, allowing therapy at lower, more comfortable air pressures. The product targets treatment of Obstructive Sleep Apnea to improve patient adherence to CPAP therapy.
- Who are Novaresp's investors?
- Novaresp's investors include Concrete Ventures.